Assignee
AERPIO THERAPEUTICS INC
US·25 granted patents·27 pending applications·546 citations·filing 2012–2021
Top patents by PatentIndex Score
52 records- 0198US9949956B2Compounds, compositions, and methods for preventing metastasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2015·Granted Apr 24, 2018·21 cites·18 claims
- 0298USRE46592EHuman protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·25 cites·28 claims
- 0398US9795594B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2016·Granted Oct 24, 2017·30 cites·13 claims
- 0498US9174950B2Compounds, compositions, and methods for preventing metastasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2014·Granted Nov 3, 2015·32 cites·20 claims
- 0597US10220048B2Compositions and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Granted Mar 5, 2019·19 cites·13 claims
- 0697US9539245B2Combination of immunotherapies with activators of Tie-2AERPIO THERAPEUTICS INC·Filed 2015·Granted Jan 10, 2017·37 cites·40 claims
- 0797US9440963B2Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2014·Granted Sep 13, 2016·35 cites·60 claims
- 0897US9284285B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2014·Granted Mar 15, 2016·27 cites·10 claims
- 0997US9126958B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2014·Granted Sep 8, 2015·31 cites·17 claims
- 1097US9096555B2Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2012·Granted Aug 4, 2015·32 cites·2 claims
- 1197US8895563B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2013·Granted Nov 25, 2014·35 cites·27 claims
- 1297US8883832B2Compounds, compositions, and methods for preventing metastasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2013·Granted Nov 11, 2014·38 cites·52 claims
- 1397US8846685B2Human protein tyrosine phosphatase inhibitors and methods of useAERPIO THERAPEUTICS INC·Filed 2012·Granted Sep 30, 2014·37 cites·4 claims
- 1496US8999325B2Treatment of ocular diseaseAERPIO THERAPEUTICS INC·Filed 2012·Granted Apr 7, 2015·36 cites·18 claims
- 1595US10329357B2Treatment of ocular diseaseAERPIO THERAPEUTICS INC·Filed 2017·Granted Jun 25, 2019·16 cites·11 claims
- 1695US10253094B2Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditionsAERPIO THERAPEUTICS INC·Filed 2017·Granted Apr 9, 2019·13 cites·45 claims
- 1795US10150811B2Methods for treating vascular leak syndrome and cancerAERPIO THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·15 cites·14 claims
- 1895US9926367B2Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereofAERPIO THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·23 cites·11 claims
- 1993US9278930B2Methods for increasing the stabilization of hypoxia inducible factor-αAERPIO THERAPEUTICS INC·Filed 2015·Granted Mar 8, 2016·8 cites·13 claims
- 2093US8883774B2Methods for increasing the stabilization of hypoxia inducible factor-1 alphaAERPIO THERAPEUTICS INC·Filed 2013·Granted Nov 11, 2014·12 cites·12 claims
- 2192US8999971B2Methods for increasing the stabilization of hypoxia inducible factor-1 alphaAERPIO THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·10 cites·20 claims
- 2290US9540326B2Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2015·Granted Jan 10, 2017·5 cites·12 claims
- 2388US9994560B2HPTP-β inhibitorsAERPIO THERAPEUTICS INC·Filed 2015·Granted Jun 12, 2018·8 cites·36 claims
- 2480US2022185778A1Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2572US2018237429A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2672US2018237430A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2772US2018237431A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2870US10562854B2Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2018·Granted Feb 18, 2020·0 cites·13 claims
- 2970US2015050277A1Compositions and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3069US2018022741A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3168US2019076405A1Compounds, compositions, and methods for preventing metasasis of cancer cellsAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3268US2018251457A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3367US2016220540A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3466US2019231799A1Compositions and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3565US2017298019A1Prolyl hydroxylase inhibitorsAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3665US2020010565A1Treatment of ocular diseaseAERPIO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3764US9388135B2Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2-(1H)-onesAERPIO THERAPEUTICS INC·Filed 2015·Granted Jul 12, 2016·1 cites·29 claims
- 3863US2014066458A1Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3963US2013331386A1Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4063US2018092883A1Phosphatase inhibitors for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4163US2016220541A1Compositions, formulations and methods for treating ocular diseasesAERPIO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4262US2019023773A1ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOFAERPIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4361US2014044707A1ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES TEHREOFAERPIO THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4461US2018016245A1Methods for treating vascular leak syndromeAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4558US2014288134A1Compositions and methods for treating ocular edema, neovascularization and related diseasesAERPIO THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4657US2013095065A1Methods for Treating Vascular Leak Syndrome and CancerAERPIO THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4753US2015232575A1Treatment of ocular diseasesAERPIO THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4853US2018037579A1Compositions and methods for treating ocular edema, neovascularization and related diseasesAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4952US2018353614A1VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy VectorAERPIO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5047US2016082129A1VE-PTP Extracellular Domain Antibodies Delivered by a Gene Therapy VectorAERPIO THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →